TheJobsMapNanoscope Therapeutics Inc. jobs and careers
Dallas, United States
About Nanoscope Therapeutics Inc.
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope’s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells. Update: June, 2021: Nanoscope Therapeutics Announces FDA Approval of IND for Phase 2b clinical trial of Optogenetic Gene Monotherapy to Restore Vision in Patients with Retinitis Pigmentosa
Founded in 2017 by Samarendra Mohanty and Sulagna Bhattacharya.
- Founded
- 2017
- Employees
- 11 to 50
- Total funding
- $3.5M
- Headquarters
- Dallas
Leadership
The top of Nanoscope Therapeutics Inc.'s org chart, with how many people report into each leader.
Sulagna Bhattacharya
Chief Executive Officer & Co-founder
24 reports
Khandan Baradaran
Senior Vice President
10 reports
Michael Marquez
CFO
3 reports
Samarendra Mohanty
Chief Scientific Officer
1 report
Ramesh Arjunji
Executive Vice President, Value & Access
1 report
Samuel Barone
Chief Medical Officer
1 report
Ashish Patel Mba
Senior Vice President, Sales And Marketing
Anthony Togba
Chief Financial Officer
Najam Sharif
Vice President, Global Research & Development
Jobs at Nanoscope Therapeutics Inc.
No open positions right now. Explore more companies on TheJobsMap.